EoE patient biopsies treated with glucocorticoids show gene expression profiles similar to control individuals, as glucocorticoids inhibit IL-13-induced eotaxin-3 through the expression of FKBP51 [132]. Here, CCL26 is linked to eosinophilic esophagitis.